Disease / condition

Prostate cancer clinical trials

Free access to 375 studies·10+ countries·Updated daily110 recruiting
375
Total trials
10+
Countries
10+
Sponsors
110
Recruiting
By phase
N/A176
Not Applicable73
Phase 249
Early Phase 136
Phase 315
By status
Recruiting110
Completed102
Not yet recruit...63
Unknown31
Recruitment Com...26
Top countries
Japan137
China93
Australia43
Netherlands17
United Kingdom9
Top sponsors
Qilu Hospital of S...4
Edith Cowan Univer...4
Tohoku University4
Chinese PLA Genera...4
Department of Urol...3
Recent trials
Latest clinical trials for Prostate cancer
2020-000543-31
An Adaptive Phase 2, Open-Label, Multicentre Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix Trifluoroacetate, a Gonadotropin-releasing Hormone (GnRH) A...
Antev Ltd.
UMIN000050538Recruiting
Radiotherapy with hyperthermia for patients with high-risk prostate cancer; a multicenter prospective observational study
Aichi Medical UniversityJapan
jRCT2031220674Recruiting
Untitled Trial
Astellas Pharma Global Develop...United States of America;Argentina;Australia;Belgium;Canada;Chile;Czech;Denmark;Finland;France;Georg
ANZCTR12623000160639·Phase 2Not yet recr...
A Randomized, Open-Label, Phase 2 Study of Darolutamide as Single Agent or in Combination with EPI-7386 as a Neoadjuvant Treatment for Patients Undergoing Prostatectomy for Localized Prostate Cancer (DaSCENT)
St Vincent's Hospital SydneyAustralia
ANZCTR12623000073606·Early Phase 1Not yet recr...
A Single-Arm, Open-Label, Prospective, Phase 0 Trial Evaluating the Safety and Efficacy of Salvage 177Lu-PSMA-I&T in Prostate Specific Antigen (PSA) Biochemical Failure After Radical Prostatectomy for High-Risk Prostate Cancer
Dr Anthony-Joe NassourAustralia
UMIN000049746·Phase 2Recruiting
A Confirmatory Clinical Trial of Two-fractionated Stereotactic Magnetic Resonance-guided Adaptive Radiation Therapy for Prostate Cancer Patients
National Cancer CenterJapan
ANZCTR12622001478707·Not ApplicableNot yet recr...
Evaluating the efficacy of radiation therapy compared to surveillance in men with prostate cancer that has returned after surgery and negative Prostate specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) scan.
The Australian and New Zealand...Australia
UMIN000049304Enrolling by...
Randomized Phase II selection trial of Stereotactic Prostate Irradiation with Dose Escalated Region
Kitasato univeristyJapan
jRCT1032220391Recruiting
Untitled Trial
2022-001410-20Ongoing
Determining the clinical relevance of the interaction between enzalutamide and the opioid morphine and the DOAC edoxaban to improve rational pharmacological care of patients with prostate cancer
Radboud university medical cen...
ChiCTR2200062729Recruiting
Untitled Trial
Department of urology, The Fir...China
UMIN000047981Not yet recr...
Effect of tadarafil on lower urinary tract symptoms in patients treated with low dose rate brachytherapy for prostate cancer
Nara Medical UniversityJapan
ChiCTR2200060566·Phase 2Not yet recr...
Untitled Trial
Qilu Hospital of Shandong Univ...China
jRCT2031220104Recruitment ...
Untitled Trial
Novartis Pharma. K.K.United States of America;Austria;Belgium;Canada;Denmark;France;South Korea;Netherlands;Poland;Singap
jRCTs052220034Recruitment ...
Untitled Trial
UMIN000047536Recruiting
Biochemical adaptive radiation therapy based on prostate-specific antigen response in salvage radiation therapy for postoperative biochemical failure of prostate cancer.
Kamagaya General HospitalJapan
2021-000486-33Ongoing
99mTc-MIP-1404 SPECT/CT for primary PROstate cancer STAging: comparative prospective, randomized trial to present guideline imaging
Turku University Hospital
ChiCTR2200057223·Not ApplicableNot yet recr...
Untitled Trial
Sun Yat-Sen Memorial Hospital ...China
ChiCTR2200056386·Not ApplicableNot yet recr...
Untitled Trial
The first affiliated hospital ...China
ChiCTR2200055401·Not ApplicableNot yet recr...
Untitled Trial
Sichuan Cancer HospitalChina
About this record

Access comprehensive clinical trial information for Prostate cancer through Pure Global AI's free database. This collection includes 375 clinical trials across multiple phases including N/A, Not Applicable, Phase 2. Currently, 110 trials are actively recruiting participants.

Research for Prostate cancer is being conducted in Japan, China, Australia and 7+ other countries. Leading sponsors include Qilu Hospital of Shandong University and Edith Cowan University. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 375 clinical trials studying Prostate cancer, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include Qilu Hospital of Shandong University, Edith Cowan University, Tohoku University, among others.